Mr. Svennilson has twenty-five years of experience in corporate finance, investment banking, and venture capital. He was the founder and a partner of Three Crowns Capital, a leading backer of a new generation of U.S. biotechnology companies. He helped found companies like Rosetta, PTC, Tercica and Somalogic and over the past sixteen years has helped finance and develop biotech companies such as Tularik, Sunesis, Chemocentryx, Infinity, AVEO, Rinat and FivePrime. He is currently a Board Director of NGM Biopharmaceuticals, Aragon Pharmaceuticals and PTC Therapeutics and has served on the Board of Directors of several other biotechnology companies including Rosetta, Somalogic and ChemoCentryx. Prior to Three Crowns Capital he was the Associate Managing Director in charge of European Investment Banking Origination at Nomura Securities in London. Mr. Svennilson is currently a Trustee for The Institute for Advanced Study in Princeton, New Jersey.

TCG Board Representation: Aragon Pharmaceuticals, NGM Biopharmaceuticals, PTC Therapeutics